⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CLDX News
Celldex Therapeutics, Inc
Celldex to Present at Upcoming Investor Conference
globenewswire.com
CLDX
Ric Burns' Acclaimed NEW YORK: A DOCUMENTARY FILM Returns with Two New Films September 21st and 22nd On PBS
prnewswire.com
AMX
GOOG
CMCSA
IBM
MSFT
NVDA
INTC
META
AMZN
NFLX
ABNB
UBER
LYFT
TSLA
GM
F
RIVN
NIO
XPEV
LI
PLTR
SNOW
CRM
ADBE
GOOGL
MSCI
SPGI
BKNG
EXPE
MAR
H
WYNN
LVS
MGM
CHTR
VZ
T
QCOM
AMD
MU
AMAT
ASML
TXN
NXPI
ON
ADI
LRCX
KLAC
MRVL
WDC
SE
BABA
JD
PDD
BIDU
BILI
IQ
VIPS
HTHT
NTES
EDU
BEKE
RMAX
Z
HOFT
PG
KO
PEP
MCD
SBUX
YUM
CMG
WEN
CAKE
BJRI
EAT
DRI
BLMN
TH
QSR
SONO
BBY
WMT
TGT
HD
LOW
COST
TJX
ROST
M
KSS
URBN
ANF
AEO
LULU
NKE
UA
CROX
RL
PVH
TPR
CPRI
KHC
GIS
CL
EL
ORCL
SAP
ACN
HPQ
DELL
CSCO
INTU
PYPL
AXP
V
MA
JPM
BAC
WFC
C
MS
GS
SCHW
RJF
LPLA
BEN
IVZ
AB
PGR
ALL
TRV
CB
UNM
MET
PRU
AIG
LNC
GL
CCI
AMT
EQIX
DLR
COR
NTAP
STX
WD
CDNS
SNPS
QTRX
REGN
GILD
AMGN
BMY
ABBV
LLY
PFE
MRK
JNJ
BIIB
VRTX
ALKS
AZN
SNY
NVS
CRSP
EDIT
NTLA
BNTX
MRNA
EXAS
ILMN
ROKU
CRWD
COIN
MARA
RIOT
FTFT
BTBT
CLSK
HUT
GLXY
NNDM
IONQ
RIG
NVCR
CRBU
ACRS
APLS
AXSM
CLDX
CRBP
CUE
CYTK
DASH
GRWG
PLUG
FCEL
BE
NEE
DUK
SO
EXC
SRE
PCG
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Celldex Therapeutics, Inc. (NASDAQ: CLDX)
prnewswire.com
CLDX
Global Neurodegenerative Disease Market is Expected to Showcase Significant Growth at a CAGR of ~6% by 2034 | DelveInsight
globenewswire.com
NVO
LLY
BMY
AXSM
JNJ
SNY
BIIB
ABBV
MRK
REGN
GILD
AMGN
AZN
TEVA
BHC
ALKS
VRTX
SRPT
CRIS
NTLA
EDIT
INCY
ACAD
ALNY
CYTK
IONS
EXAS
IDXX
VNDA
SUPN
RGNX
XOM
CVAC
BNTX
ARCT
MRNA
NBIX
ADPT
AVXL
IMUX
PRGS
RDNT
CRDF
ADSK
ANAB
ATRC
CLDX
CPRX
ESPR
EXEL
FGEN
GALT
GRFS
HRMY
IGC
INSM
KODK
LAKE
LCTX
LEXX
LPCN
MESO
MITK
MNKD
MSFT
MYGN
NEO
NVCR
NXPI
OCGN
OMER
ORCL
PACB
PFE
PLRX
PRGO
PSNL
PTGX
QGEN
RARE
ROST
RVMD
SEIC
SIGA
SMCI
SNOW
SOFI
SPRO
TGTX
TNDM
TXG
ULTA
VEEV
VKTX
VRNS
WVE
XRAY
ZBRA
ZNTL
Form 8-K
sec.gov
CLDX
Celldex Reports Second Quarter Financial Results and Provides Corporate Update
globenewswire.com
CLDX
Celldex Reports Second Quarter Financial Results and Provides Corporate Update
globenewswire.com
CLDX
Celldex Reports Results from Phase 2 Study of Barzolvolimab in Prurigo Nodularis
globenewswire.com
CLDX
Form 8-K
sec.gov
CLDX
Celldex Announces Planned Transition of Chief Financial Officer
globenewswire.com
CLDX